Bank Of America Corp Bio Cardia, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.38 - $0.68 $6 - $10	-16 Reduced 0.24%	6,528 $2,000
Q4 2023 Feb 14, 2024	BUY	$0.37 - $1.07 $5 - $17	16 Added 0.25%	6,544 $4,000
Q1 2023 May 12, 2023	SELL	$1.87 - $2.54 $48 - $66	-26 Reduced 0.4%	6,528 $12,000
Q4 2022 Feb 10, 2023	BUY	$1.61 - $32.1 $41 - $834	26 Added 0.4%	6,554 $13,000
Q1 2022 May 16, 2022	SELL	$21.3 - $39.0 $298 - $546	-14 Reduced 0.21%	6,528 $14,000
Q4 2021 Feb 08, 2022	BUY	$25.65 - $46.05 $4,693 - $8,427	183 Added 2.88%	6,542 $13,000
Q3 2021 Nov 15, 2021	BUY	$42.6 - $58.65 $26,582 - $36,597	624 Added 10.88%	6,359 $20,000
Q2 2021 Sep 13, 2021	BUY	$48.9 - $74.85 $280,441 - $429,264	5,735 New	5,735 $23,000

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $39.8M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.